294 related articles for article (PubMed ID: 6229053)
1. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
Balch CM; Dougherty PA; Cloud GA; Tilden AB
Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
[TBL] [Abstract][Full Text] [Related]
2. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
Balch CM; Dougherty PA; Tilden AB
Ann Surg; 1982 Dec; 196(6):645-50. PubMed ID: 6216863
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin enhancement of immunocompetence in melanoma patients.
Tilden AB; Balch CM
Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
[TBL] [Abstract][Full Text] [Related]
4. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
Tilden AB; Balch CM
Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
[TBL] [Abstract][Full Text] [Related]
5. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
Fischer A; Durandy A; Griscelli C
J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
[TBL] [Abstract][Full Text] [Related]
6. The role of prostaglandin E2 in immune suppression following injury.
Grbic JT; Mannick JA; Gough DB; Rodrick ML
Ann Surg; 1991 Sep; 214(3):253-62; discussion 262-3. PubMed ID: 1929607
[TBL] [Abstract][Full Text] [Related]
7. Immune dysfunction in primary biliary cirrhosis. II. Increased production of prostaglandin E.
Chiricolo M; Lenzi M; Bianchi F; Franceschi C; Bartolini G; Orlandi M; Tomasi V; Licastro F
Scand J Immunol; 1989 Sep; 30(3):363-7. PubMed ID: 2789430
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.
Wanebo HJ; Riley T; Katz D; Pace RC; Johns ME; Cantrell RW
Cancer; 1988 Feb; 61(3):462-74. PubMed ID: 2962730
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
Awara W; Hillier K; Jones D
Immunology; 1986 Dec; 59(4):557-62. PubMed ID: 3468061
[TBL] [Abstract][Full Text] [Related]
10. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
Koster FT; Williams JC; Goodwin JS
J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
[TBL] [Abstract][Full Text] [Related]
12. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients.
Han T; Nemoto T; Ledesma EJ; Bruno S
Int J Immunopharmacol; 1983; 5(1):11-5. PubMed ID: 6601630
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
Goodwin JS; Messner RP; Peake GT
J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma.
Murray JL; Kollmorgen GM
J Clin Immunol; 1983 Jul; 3(3):268-76. PubMed ID: 6224806
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.
Goodwin JS; Messner RP
J Clin Invest; 1979 Aug; 64(2):434-9. PubMed ID: 457862
[TBL] [Abstract][Full Text] [Related]
17. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
Licastro F; Lenzi M; Chiricolo M; Davis LJ; Cassani F; Bianchi F; Franceschi C
J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF).
Rocklin RE; Kiselis I; Beer DJ; Rossi P; Maggi F; Bellanti JA
Cell Immunol; 1983 Apr; 77(1):92-8. PubMed ID: 6573232
[TBL] [Abstract][Full Text] [Related]
19. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
Schambelan M; Blake S; Sraer J; Bens M; Nivez MP; Wahbe F
J Clin Invest; 1985 Feb; 75(2):404-12. PubMed ID: 3156147
[TBL] [Abstract][Full Text] [Related]
20. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
Mizushima Y; Wepsic HT; Yamamura Y; Desilva MA
Clin Exp Immunol; 1984 Aug; 57(2):371-9. PubMed ID: 6235988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
